Will Sirtuin 2 Be a Promising Target for Neuroinflammatory Disorders?

Area of Science:

• Neuroscience
• Immunology
• Molecular Biology

Background:

• Neuroinflammatory disorders involve progressive neuronal damage and are linked to neurodegenerative and neuropsychiatric conditions like Alzheimer's and Parkinson's disease.
• While moderate neuroinflammation supports brain function, excessive inflammation impairs neuronal regeneration and damages the central nervous system.
• Targeting neuroinflammation presents a promising therapeutic avenue beyond symptomatic treatments.

Purpose of the Study:

• To review the current understanding of how Sirtuin 2 (SIRT2) influences immune homeostasis in neuroinflammatory disorders.
• To explore the structure, catalytic properties, and inhibitors of SIRT2.
• To discuss the multifaceted role of SIRT2 in various diseases characterized by neuroinflammation.

Main Methods:

• Literature review summarizing recent advancements in SIRT2 research related to neuroinflammation.
• Analysis of SIRT2's deacetylation properties and their impact on immune regulation.
• Discussion of selective SIRT2 inhibitors and their therapeutic potential.

Main Results:

• Sirtuin 2 (SIRT2), a class III histone deacetylase, is implicated in modulating inflammation and immune homeostasis.
• SIRT2's deacetylation activity regulates key cellular processes, including senescence, autophagy, and myelin formation, impacting neuroinflammation.
• The review highlights SIRT2's involvement in diverse neuroinflammatory conditions, underscoring its therapeutic relevance.

Conclusions:

• SIRT2 is a critical regulator of immune homeostasis and a potential therapeutic target for neuroinflammatory disorders.
• Understanding SIRT2's mechanisms offers new strategies for treating conditions like Alzheimer's disease, Parkinson's disease, and stroke.
• Further research into selective SIRT2 inhibitors is warranted for effective neuroinflammatory disease management.